J P McCormack1, R Li, D Zarowny, J Singer. 1. Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of British Columbia, Vancouver, Canada.
Abstract
OBJECTIVE: To evaluate the prevalence of pain, how pain affects patients' lives, what treatments are being used, and the effectiveness of these pain treatments in ambulatory patients with human immunodeficiency virus (HIV) disease. DESIGN: A self-administered pain survey (modified version of the Wisconsin Brief Pain Questionnaire). SETTING: An ambulatory infectious disease clinic that deals mainly with ambulatory HIV patients. PATIENTS: Ambulatory HIV patients. OUTCOME MEASURES: Results of the response to the questionnaire. RESULTS: Eighty-two of 148 patients surveyed had pain due to their disease in the month prior to completing the survey. Of those reporting pain, 60-70% reported that their pain interfered with aspects of their daily lives from a moderate to severe degree. In patients with pain, 40% reported that they were not receiving any pain treatment. Those patients who were receiving treatment only obtained a mean pain relief of 65%. CONCLUSIONS: Pain is an important problem in terms of its prevalence and impact on patients with HIV disease. Pain control in this patient population is inadequate. Clinicians should realize that pain can be present regardless of the duration of the disease and its severity. Patients need to be educated about the proper use of pain medications and helped to understand that pain medications will not "worsen their disease."
OBJECTIVE: To evaluate the prevalence of pain, how pain affects patients' lives, what treatments are being used, and the effectiveness of these pain treatments in ambulatory patients with human immunodeficiency virus (HIV) disease. DESIGN: A self-administered pain survey (modified version of the Wisconsin Brief Pain Questionnaire). SETTING: An ambulatory infectious disease clinic that deals mainly with ambulatory HIVpatients. PATIENTS: Ambulatory HIVpatients. OUTCOME MEASURES: Results of the response to the questionnaire. RESULTS: Eighty-two of 148 patients surveyed had pain due to their disease in the month prior to completing the survey. Of those reporting pain, 60-70% reported that their pain interfered with aspects of their daily lives from a moderate to severe degree. In patients with pain, 40% reported that they were not receiving any pain treatment. Those patients who were receiving treatment only obtained a mean pain relief of 65%. CONCLUSIONS:Pain is an important problem in terms of its prevalence and impact on patients with HIV disease. Pain control in this patient population is inadequate. Clinicians should realize that pain can be present regardless of the duration of the disease and its severity. Patients need to be educated about the proper use of pain medications and helped to understand that pain medications will not "worsen their disease."
Authors: Michael J Silverberg; Gary Thomas Ray; Kathleen Saunders; Carolyn M Rutter; Cynthia I Campbell; Joseph O Merrill; Mark D Sullivan; Caleb J Banta-Green; Michael Von Korff; Constance Weisner Journal: Clin J Pain Date: 2012-01 Impact factor: 3.442
Authors: Luke Hansen; Joanne Penko; David Guzman; David R Bangsberg; Christine Miaskowski; Margot B Kushel Journal: J Pain Symptom Manage Date: 2011-07-30 Impact factor: 3.612
Authors: Christine Miaskowski; Joanne M Penko; David Guzman; Jennifer E Mattson; David R Bangsberg; Margot B Kushel Journal: J Pain Date: 2011-09 Impact factor: 5.820
Authors: Jean L Richardson; Bonnie Heikes; Roksanna Karim; Kathleen Weber; Kathryn Anastos; Mary Young Journal: AIDS Patient Care STDS Date: 2009-07 Impact factor: 5.078